+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharmaniaga Berhad (PHARMA) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 51 Pages
  • May 2023
  • GlobalData
  • ID: 2081858
Pharmaniaga Berhad (PHARMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pharmaniaga Berhad (Pharmaniaga), a member of Boustead Group is an investment holding company. It is an integrated pharmaceutical group that operates across a wide spectrum of the healthcare industry through its subsidiaries. The company carries out logistics and distribution and manufacturing of generic pharmaceuticals; and sales, marketing, and distribution of medical products and hospital equipment. Pharmaniaga operates community pharmacies in Malaysia; and provides pharmaceutical products, diagnostic products and food supplements in Indonesia. The company has manufacturing facilities and logistics and distribution warehouses in Malaysia and Indonesia; and operates across the regions. Pharmaniaga is headquartered at Shah Alam, Selangor, Malaysia.

Pharmaniaga Berhad Key Recent Developments

  • May 18, 2023: Pharmaniaga demonstrates resilience with positive results in Q1 Fy2023
  • Aug 19, 2022: Pharmaniaga Berhad announced its quarterly results for the financial period ended 30 June 2022
  • Jul 20, 2022: Pharmaniaga announce appointment of Dr Mary jane cardosa
  • Jul 20, 2022: Pharmaniag announce appointment of Datuk lim thean shiang

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Pharmaniaga Berhad - Key Facts
  • Pharmaniaga Berhad - Key Employees
  • Pharmaniaga Berhad - Key Employee Biographies
  • Pharmaniaga Berhad - Major Products and Services
  • Pharmaniaga Berhad - History
  • Pharmaniaga Berhad - Company Statement
  • Pharmaniaga Berhad - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Pharmaniaga Berhad - Business Description
  • Business Segment: Eliminations
  • Performance
  • Business Segment: Indonesia
  • Overview
  • Performance
  • Business Segment: Logistics and Distribution
  • Overview
  • Performance
  • Business Segment: Manufacturing
  • Overview
  • Performance
  • Geographical Segment: Indonesia
  • Performance
  • Geographical Segment: Malaysia
  • Performance
  • Geographical Segment: Other Countries
  • Performance
  • R&D Overview
  • Pharmaniaga Berhad - Corporate Strategy
  • Pharmaniaga Berhad - SWOT Analysis
  • SWOT Analysis - Overview
  • Pharmaniaga Berhad - Strengths
  • Pharmaniaga Berhad - Weaknesses
  • Pharmaniaga Berhad - Opportunities
  • Pharmaniaga Berhad - Threats
  • Pharmaniaga Berhad - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Pharmaniaga Berhad, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 18, 2023: Pharmaniaga demonstrates resilience with positive results in Q1 Fy2023
  • Aug 19, 2022: Pharmaniaga Berhad announced its quarterly results for the financial period ended June 2022
  • Jul 20, 2022: Pharmaniaga announce appointment of Dr Mary jane cardosa
  • Jul 20, 2022: Pharmaniag announce appointment of Datuk lim thean shiang
  • Jul 20, 2022: Pharmaniaga Berhad announced board change for Datuk Lim Thean Shiang
  • Jul 20, 2022: Pharmaniaga Berhad announced board change for Dr Mary Jane Cardosa
  • May 20, 2022: Pharmaniaga Berhad announced its quarterly results for the financial period ended March 2022
  • Apr 29, 2022: Pharmaniaga Berhad announced 2022 annual report
  • Apr 28, 2022: Pharmaniaga Berhad general meeting notice
  • Feb 17, 2022: Pharmaniaga Bhd Quarterly report on consolidated results for the financial period ended 31/12/2021
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Pharmaniaga Berhad, Key Facts
  • Pharmaniaga Berhad, Key Employees
  • Pharmaniaga Berhad, Key Employee Biographies
  • Pharmaniaga Berhad, Major Products and Services
  • Pharmaniaga Berhad, History
  • Pharmaniaga Berhad, Subsidiaries
  • Pharmaniaga Berhad, Key Competitors
  • Pharmaniaga Berhad, Ratios based on current share price
  • Pharmaniaga Berhad, Annual Ratios
  • Pharmaniaga Berhad, Interim Ratios
  • Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Pharmaniaga Berhad, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Pharmaniaga Berhad, Performance Chart (2018 - 2022)
  • Pharmaniaga Berhad, Ratio Charts
  • Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Sunzen Biotech Berhad
  • IHH Healthcare Berhad
  • Hovid Berhad
  • Duopharma Biotech Berhad
  • Apex Healthcare Berhad
  • Carotech Bhd
  • BP Labs